George C Lombardi

A Fellow of the American College of Trial Lawyers, George’s skills have been widely recognized by a number of the leading legal directories. The American Lawyer (2014), named him a “Litigator of the Year.” He is described by IAM Patent 1000 as a “truly gifted lawyer and one of the finest trial lawyers anywhere in the world,” and recognized as a 2026 IAM Global Leader.

George routinely serves as lead trial counsel in all types of litigation ranging from complex commercial disputes to mass torts to patent cases. He has handled and continues to handle various other patent cases involving telephone and computer technology, medical devices and instruments, and pharmaceuticals. Notably, he has obtained trial wins in matters involving a number of top-selling drugs, including: Zubsolv®, Prozac®, Yasmin®, Baraclude®, Razadyne ER/Razadyne IR®, Temodar®, Amrix®, Amprya®, Sensipar®, and Testim®, among others. Many of his cases have involved first of their kind wins. For instance, the Baraclude® case was the first ANDA case finding obviousness of a chemical compound patent, and the Prozac® case was called the “Mother of All Patent Challenges” by Fortune magazine. He recently obtained a trial victory in a case involving the brand drug Zubsolv®.

Outside of the patent arena, George has secured numerous victories for a variety of clients in jurisdictions across the country. George’s trials have involved securities and commodities laws, consumer fraud acts, trade secrets, employment discrimination, breach of contract, state environmental laws and white collar criminal defense among others.